Although relatively small numbers of patients have been analyzed, these clinical data linking development of HEV to improved tumor immunity are supported by experimental studies in mice where the development of PNAd and/or MAdCAM-1 expressing vessels correlates with reduced tumor growth, increased recruitment of naive/central memory T cells and/or local expansion of T cells within the tumor.78-80. The gene discussed is NTAN1; the disease is neoplasm.